key: cord-0983292-g3h448gl
authors: Bayhan, Turan; Şahin, Seda; Çulha, Vildan; Özbek, Namık; Yaralı, Neşe
title: Pediatric patients with benign hematological diseases during the COVID‐19 pandemic
date: 2020-07-15
journal: Pediatr Blood Cancer
DOI: 10.1002/pbc.28595
sha: 7a928f40797453268d605e701208de72c92230f1
doc_id: 983292
cord_uid: g3h448gl

nan

To the Editor:

After the rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) around the world, World Health Organization declared a pandemic on March 11, 2020. The SARS-CoV-2 pandemic is devastating due to the high mortality coronavirus disease 2019 (COVID-19), besides putting extensive pressure on health care systems. 1 Turkey has many restrictions to control the outbreak during the pandemic period, and normalization started in June 2020.

In our study, we aimed to investigate the health problems of patients with benign hematological disorders during the restrictions period.

We included children with benign hematological diseases followed in the Ministry of Health Ankara City Hospital Department of Pediatric Hematology, except those with transfusion-dependent thalassemia major. We called the parents of the patients and filled a questionnaire about the clinical condition, inability to access medication, or health care of patients between March 10 and May 31, 2020.

We analyzed the data of 140 patients with benign hematological disorders. The median age was 12 (range 0.5-28) years, and female/male ratio was 44/96. The majority of patients had hemophilia, acute or chronic immune thrombocytopenic purpura, or hemolytic anemia (Table 1) . Sixty-five of the patients (46.4%) were taking at least one drug for their disease, and three were being treated with immunosuppressive therapy. One hundred and one patients lived in the city where our hospital is located, while others were in other cities. Five of the patients underwent a polymerase chain reaction test for COVID-19. One patient with the diagnosis of aplastic anemia was positive for SARS-CoV-2 and was hospitalized. Six patients had COVID-19-positive relatives. During the study period, 61 patients had an appointment in our pediatric hematology clinic; however, only 18 (29.5%) patients visited the clinic. Six parents called the clinic for their children's health problems. Although 29 (20.7%) patients had an emergent hematological problem during this period, 18 (62%) of them were not seen by any health care provider. The most common problem was bleeding ( Table 1) . None of our patients had any difficulty in obtaining their drugs except one with inhibitor-positive hemophilia who lived in another city.

Recent studies revealed that there is no increased mortality risk secondary to COVID-19 in pediatric patients with immune suppression. 2, 3 Patients with benign hematological disorders are susceptible to problems in health care. Besides infection risk, patients with chronic diseases are at risk due to the lack of admission to specialized centers during the pandemic period. 4 In Turkey during the pandemic, patients with chronic diseases were able to take their medication without a pre- 

COVID-19 and Italy: what next?

Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs

Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment

Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic